Selective Induction of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Atrial and Ventricular Myocardium in Patients With Atrial Fibrillation

Boldt, 2004, Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease, Heart, 90, 400, 10.1136/hrt.2003.015347 Kostin, 2002, Structural correlate of atrial fibrillation in human patients, Cardiovasc Res, 54, 361, 10.1016/S0008-6363(02)00273-0 Xu, 2004, Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation, Circulation, 109, 363, 10.1161/01.CIR.0000109495.02213.52 Li, 2001, Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure, Circulation, 104, 2608, 10.1161/hc4601.099402 Hanna, 2004, Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure, Cardiovasc Res, 63, 236, 10.1016/j.cardiores.2004.03.026 Nagatomo, 2000, Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control, Am J Physiol Heart Circ Physiol, 278, H151, 10.1152/ajpheart.2000.278.1.H151 Woodiwiss, 2001, Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction, Circulation, 103, 155, 10.1161/01.CIR.103.1.155 Boixel, 2003, Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat, J Am Coll Cardiol, 42, 336, 10.1016/S0735-1097(03)00578-3 Hoit, 2002, Remodeling of the left atrium in pacing-induced atrial cardiomyopathy, Mol Cell Biochem, 238, 145, 10.1023/A:1019988024077 Thomas, 1998, Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy, Circulation, 97, 1708, 10.1161/01.CIR.97.17.1708 Mukherjee, 2003, Myocardial infarct expansion and matrix metalloproteinase inhibition, Circulation, 107, 618, 10.1161/01.CIR.0000046449.36178.00 Spinale, 1999, Matrix metalloproteinase inhibition during the development of congestive heart failure, Circ Res, 85, 364, 10.1161/01.RES.85.4.364 Wilson, 2003, Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling, Circulation, 107, 2857, 10.1161/01.CIR.0000068375.40887.FA Spinale, 2000, A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure, Circulation, 102, 1944, 10.1161/01.CIR.102.16.1944 Nakano, 2004, Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation, J Am Coll Cardiol, 43, 818, 10.1016/j.jacc.2003.08.060 Marotta, 1985, Sensitive spectrophotometric method for the quantitative estimation of collagen, Anal Biochem, 150, 86, 10.1016/0003-2697(85)90443-9 Tullberg-Reinert, 1999, In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay, Histochem Cell Biol, 112, 271, 10.1007/s004180050447 Frustaci, 1997, Histological substrate of atrial biopsies in patients with lone atrial fibrillation, Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180 Ausma, 2003, Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat, Circulation, 107, 2051, 10.1161/01.CIR.0000062689.04037.3F Moe, 1959, Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge, Am Heart J, 58, 59, 10.1016/0002-8703(59)90274-1 Wijffels, 1995, Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats, Circulation, 92, 1954, 10.1161/01.CIR.92.7.1954 Aime-Sempe, 1999, Myocardial cell death in fibrillating and dilated human right atria, J Am Coll Cardiol, 34, 1577, 10.1016/S0735-1097(99)00382-4 Schotten, 2001, Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation, Circulation, 103, 691, 10.1161/01.CIR.103.5.691 Verheule, 2004, Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-β1, Circ Res, 94, 1458, 10.1161/01.RES.0000129579.59664.9d L’Allier, 2004, Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation, J Am Coll Cardiol, 44, 159, 10.1016/j.jacc.2004.03.056 Vermes, 2003, Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction, Circulation, 107, 2926, 10.1161/01.CIR.0000072793.81076.D4 Marin, 2003, Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?, Stroke, 34, 1181, 10.1161/01.STR.0000065431.76788.D9